Tsumura & (4540.T) Osake Kurssi

Tsumura & Co is primarily active in the pharmaceutical and healthcare industries.

Tsumura & Co faces competition from several key players in the market. Some of the main competitors include Kampo Seiyaku, Kracie Holdings, Taisho Pharmaceutical, and Otsuka Pharmaceutical. These companies also operate in the pharmaceutical industry, offering diverse product portfolios and competing for market share. Tsumura & Co strives to differentiate itself through its unique product offerings, innovative research, and strong branding strategies. By closely monitoring its competitors and continuously adapting to market dynamics, Tsumura & Co aims to maintain its position as a top player in the industry.

Tsumura & Co is a Japanese pharmaceutical company founded in 1893 by Sei-ichiro Tsumura. It specializes in developing and manufacturing traditional herbal medicines known as Kampo. With over a century of experience, Tsumura has become a leading provider of high-quality Kampo products, blending traditional knowledge with modern research techniques. The company's commitment to quality and safety has earned them a strong reputation not just in Japan but also internationally. Tsumura & Co continues to expand its product line and invest in research and development to meet the evolving healthcare needs of people worldwide.

Tsumura & Co, a renowned company, has achieved several significant milestones. Over the years, the company has made tremendous progress in various areas. Tsumura & Co has successfully expanded its market presence globally, establishing a strong reputation in the industry. The company has consistently demonstrated its commitment to innovation by developing cutting-edge products and solutions. Tsumura & Co has also focused on sustainable practices, emphasizing environmental responsibility and social impact. With its exceptional performance, Tsumura & Co has received numerous accolades and industry recognition, solidifying its position as a leader in the market.

Tsumura & Co is primarily present in Japan, where the company is headquartered.

Tsumura & Co represents a set of core values and a corporate philosophy that guide its operations. The company is driven by a commitment to improving public health and promoting the well-being of individuals. Tsumura & Co embraces traditional Japanese medicine, developing high-quality herbal medicines and health-related products. Through continuous research, innovation, and ethical business practices, the company strives to deliver effective and safe healthcare solutions to its customers. Tsumura & Co aims to contribute to society by combining ancient wisdom with modern scientific advancements, ensuring the highest level of product reliability and customer satisfaction.

Analyytikot asettavat tällä hetkellä Tsumura &-osakkeelle keskimääräisen tavoitehinnan 4 462,50 JPY (mediaani: 4 233,00 JPY), mikä merkitsee +14,4 % viimeisimpään hintaan verrattuna. Konsensus perustuu 9 analyytikkoarvioon.

Tsumura & Analyytikkojen kursstavoitteet 2026

9 analyytikkoa arvioi tällä hetkellä Tsumura &-osaketta: 5 suosittaa ostoa, 4 pitoa ja 0 myyntiä.

Tsumura & Analyytikkojen kursstavoitteet 2026

Nykyisellä valuuttakurssilla Tsumura &-osake noteerataan hintaan 22,03 EUR (3 901,00 JPY).

Tsumura &-osake (4540.T) on listattuna 2 pörssissä, muun muassa: Tokio (JPX) (4540.T).

Tsumura & Co is a Japanese company specializing in the manufacturing and selling of traditional Chinese medicines (TCM) and health products. It was founded in 1893 and is headquartered in Tokyo, Japan. The company operates in three business areas: TCM products, branded products, and machinery and equipment. TCM products are the core business of Tsumura & Co, with over 300 products based on traditional Chinese medicine books. The company's well-known products include Tianma Gouteng Yin, Tokishigyakukagoshuyushokyoto, and Rikkunshito. These products are intended to improve health and alleviate symptoms of allergies, asthma, digestive problems, and colds. The branded products division includes cosmetics, dietary supplements, and medical devices. Notable Tsumura & Co brands include Milbon, a hair care line, and Kurenaidrink, a collagen and hyaluronic acid supplement. In the machinery and equipment division, the company offers machines and systems for the automated production of TCM products. These devices help streamline and automate the manual manufacturing process. Tsumura & Co aims to promote understanding and acceptance of TCM worldwide. The company collaborates closely with nutritionists, doctors, and scientists to ensure the effectiveness and safety of its products. It also operates its own research institutes and participates in various public-private partnerships. Tsumura & Co is a global company with branches in Asia, Europe, and North America. It exports its products to over 20 countries and has sales and marketing offices in the USA, Europe, and Asia. In its efforts to expand its business and promote the global acceptance of TCM, Tsumura & Co has formed partnerships with other companies in the healthcare sector. It collaborates with major pharmaceutical companies to conduct joint research and development programs and validate the effectiveness of TCM products. Overall, Tsumura & Co offers a wide range of products and services, making it a key player in the TCM industry. The company is dedicated to promoting understanding and acceptance of TCM worldwide and continuously expanding its product lines.

liikevaihto Tsumura & on 192,62 Mrd. JPY. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

voitto Tsumura & on 28,12 Mrd. JPY. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Tsumura &:n hinta-voitto-suhde (P/E) on tällä hetkellä 10,34. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Tsumura &-osakkeen arvostusta.

Tsumura &:n hinta-myynti-suhde (P/S) on tällä hetkellä 1,51. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Tsumura &-osakkeen arvostuskennuslukuna.

Tsumura &:n Eulpool-laatuscore on 8/10.

Tsumura &:n ISIN on JP3535800001. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Tsumura &:n WKN on 866699. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Tsumura &:n ticker on 4540.T. Tämä pörssinoteeraus käytetään Tsumura &-osakkeiden kauppaan pörssissä.